This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Law M et al. (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24: 1989–1998
McKnight TR et al. (2002) Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. J Neurosurg 97: 794–802
Langen KJ (2003) Amino acid transport studies in brain tumors. In Molecular Nuclear Medicine—The Challenge of Genomics and Proteomics to Clinical Practice, 477–485 (Eds Feinendegen LE et al.) Heidelberg: Springer-Verlag Berlin
Hamacher K and Coenen HH (2002) Efficient routine production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-L-tyrosine. Appl Radiat Isot 57: 853–856
Pauleit D et al. (2005) O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 128: 678–687
Floeth FW et al. (2005) Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. J Neurosurg 102: 318–327
Popperl G et al. (2004) Value of O-(2-[18F]fluoroethyl)-L-tyrosine PET for the diagnosis of recurrent glioma. Eur J Nucl Med Mol Imaging 31: 1464–1470
Ribom D et al. (2001) Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Cancer 92: 1541–1549
Ribom D et al. (2005) Evaluation of (11)C-methionine as a surrogate endpoint after treatment of grade 2 gliomas. J Neurooncol 71: 325–332
Stummer W et al. (2003) Fluorescence-guided resections of malignant gliomas—an overview. Acta Neurochir 88 (Suppl): S9–S12
Stummer W et al. (2005) Multicentric Phase III study on fluorescence-guided resection of malignant gliomas with 5-ALA: preliminary results on interim analysis of 270 patients [abstract #24638]. 2005 American Association of Neurosurgery Annual Meeting
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Floeth, F., Stummer, W. The value of metabolic imaging in diagnosis and resection of cerebral gliomas. Nat Rev Neurol 1, 62–63 (2005). https://doi.org/10.1038/ncpneuro0043
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0043
This article is cited by
-
Surgery Insight: the role of surgery in the management of low-grade gliomas
Nature Clinical Practice Neurology (2007)
-
PET imaging in the surgical management of pediatric brain tumors
Child's Nervous System (2007)